发明授权
US4208517A Caphalosporin compounds having at position-7 an .alpha.-etherified
hydroxyiminoarylacetamido group
失效
在位置-7处具有α-乙酰化羟基亚氨基芳基乙酰胺基的咖啡糊精化合物
- 专利标题: Caphalosporin compounds having at position-7 an .alpha.-etherified hydroxyiminoarylacetamido group
- 专利标题(中): 在位置-7处具有α-乙酰化羟基亚氨基芳基乙酰胺基的咖啡糊精化合物
-
申请号: US855080申请日: 1977-11-28
-
公开(公告)号: US4208517A公开(公告)日: 1980-06-17
- 发明人: Michael W. Foxton , Gordon I. Gregory , David M. Rogers
- 申请人: Michael W. Foxton , Gordon I. Gregory , David M. Rogers
- 申请人地址: GB2 Greenford
- 专利权人: Glaxo Operations UK Limited
- 当前专利权人: Glaxo Operations UK Limited
- 当前专利权人地址: GB2 Greenford
- 优先权: GBX49961/76 19761130
- 主分类号: C07D307/54
- IPC分类号: C07D307/54 ; C07D501/32 ; C07D501/34 ; A61K31/545
摘要:
Antibiotic compounds of the general formula ##STR1## [wherein R is a phenyl, thienyl or furyl group; R.sup.a and R.sup.b, which may be the same or different, are each selected from hydrogen, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.3-7 cycloalkyl, phenyl, naphthyl, thienyl, furyl, carboxy, C.sub.2-5 alkoxycarbonyl and cyano, or R.sup.a and R.sup.b together wth the carbon atom to which they are attached form a C.sub.3-7 cycloalkylidene or cycloalkenylidene group; R.sup.c and R.sup.d, which may be the same or different, each represents a hydrogen atom or a substituting group e.g. an alkyl group or substituted alkyl group; or R.sup.c and R.sup.d together with the nitrogen atom to which they are attached form a saturated or unsaturated heterocyclic ring which contains 5-7 ring members and which may contain additional hetero atoms, and may be substituted by lower alkyl; R.sup.e represents hydrogen or C.sub.1-4 alkyl; m and n are each 0 or 1 such that the sum of m and n is 0 or 1 and Y is selected from various oxygen and sulphur nucleophiles] and non-toxic derivatives thereof.
公开/授权文献
信息查询